Image of DXNA logo
  • Contact Us
  • |
  • Careers
    • About DxNA
      • History
      • Mission Statement
    • Executive Team
    • Board of Scientific Advisors
    • Partnering Opportunities
      • Distribution
      • OEM Licensing
      • 3rd Party Integration
    • Careers
    • News & Events
      • DxNA In the News
      • Press Releases
      • Industry Headlines
        • H5N1 - Avian Influenza
        • Malaria
        • Exotic Newcastle DIsease
        • PRRS - Porcine Reproductive and Respiratory Syndrome
        • African Swine Fever
    • Why DxNA
    • Genetic Molecular Analyses
    • Situation Analysis
    • Vital Role of Genetic Testing
    • Overview
    • Biodefense
    • Human Medicine
    • Veterinary Medicine
    • Agriculture
    • Food & Beverage Safety
    • Overview
    • What We Test For
    • Tests & Reagents
    • Request a Test
    • FAQ
    • White Paper
  • Search:
Overview
Biodefense
Human Medicine
Veterinary Medicine
Agriculture
Food & Beverage Safety

Veterinary Medicine

As with human medicine, the on-site capacity to look at DNA and RNA reinvents veterinary practice. As mentioned for MRSA, infected animals may also be vectors for the spread of other diseases to humans. These include Anthrax, Plague, Salmonellosis, Shigellosis, Streptococcosis, Tularemia, Rabies and Rift Valley Fever. Their presence makes on-site veterinary testing even more desirable. More than 69 million American households have at least one dog or cat, and there are about 60,000 veterinarians in the United States. Most vets want cutting-edge, in-house diagnostic capabilities. To them, on-site PCR testing would mean more profit, since money currently being paid to outside service providers for diagnosing companion animal diseases would instead be kept in-house.

 
  • site map
  • |
  • privacy
  • |
  • Copyright © 2012 DxNA LLC